Home » Topics » Immuno-oncology, BioWorld Science

Immuno-oncology, BioWorld Science
RSS

Dovetail issued patent for Betathine

Aug. 28, 1997

Malignant melanoma indication approved for Intron A in U.K.

Aug. 27, 1997

Theratope vaccine advances to phase III trials

Aug. 21, 1997

Novopharm Biotech antibodies poised to enter phase I

Aug. 19, 1997

NeoRx and Janssen enter agreement for Avicidin

Aug. 14, 1997

ImClone Systems earns manufacturing milestone from Merck KGaA

Aug. 4, 1997

GnRH conjugate vaccines prepared at Merck & Co.

July 30, 1997

FDA advisory committee recommends approval of rituximab

July 28, 1997

Bristol-Myers Squibb licenses cancer vaccines from Progenics

July 18, 1997

Low-dose interferon alfa nears phase III for the treatment of Sjogren's syndrome

July 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...